A network of 13 African countries has joined forces with global researchers to launch the largest clinical trial of potential Covid-19 treatments on the continent. The Anticov study, involving Antwerp’s Institute of Tropical Medicine and international research institutions, aims to identify treatments that can be used to treat mild and moderate cases of Covid-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa. The clinical trial will be carried out at 19 sites in 13 countries and led by doctors from African countries. The initiative emerged after calls for responses to the coronavirus better tailored to the developing world and the challenges of often underfunded healthcare systems. The study will test the efficacy of treatments in 2,000 to 3,000 mild-to-moderate patients in Burkina Faso, Cameroon, Ivory Coast, the Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Ghana, Guinea, Kenya, Mali, Mozambique, Sudan, and Uganda, with the aim of identifying treatments that can prevent progression of coronavirus to severe disease and also limit transmission.
SOURCE: THE GUARDIAN
More Stories
Green Taxis Form Part of Nairobi’s Near Future
Angolan Port Gets Emirati Flair
South Africa’s Beer Industry Going through Withdrawals
Safari Lodges have Been at the Forefront of Innovation that can be Applied Post Pandemic
Ugandan Startup Secures Funding for Its Remote Monitoring Solar Firms
Guinea is the First Low-income Country to Start Covid Vaccinations
Tragedy on Cameroon’s Roads
Accra Lays Former President to Rest
Will Mali’s Peace Deal Hold?
Tunisia’s Lockdown Can’t Hold Off Riots
How to Meet the Demand for Housing In Africa’s Urban Areas
Africans Become New Stars in the YouTube Scene